final exam quiz

Upload: lauren-napoli

Post on 03-Apr-2018

221 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/28/2019 Final Exam Quiz

    1/75

    IntroductionLevel I & ll Multiple Choice

    1 . A hemoglobin concentration of 19 g/dL is normal for which individual listed below? [Hint]

    1-day-old infant

    5-year-old child

    20-year-old male

    65-year-old female

    2 . If a patient were suffering from appendicitis, you would expect which cells to be increased in the peripheral blood? [Hint]

    erythrocytes

    lymphocytes

    neutrophils

    platelets

    3 . Which cells make up the biggest mass of cells in the peripheral blood? [Hint]

    erythrocytes

    platelets

    neutrophils

    lymphocytes

    4 . These cells are important in maintaining normal hemostasis: [Hint]

    erythrocytes

    platelets

    neutrophils

    monocytes

    5 . A patient has a WBC count of 25 x 10 /L. The doctor subsequently orders a differential count. This is an example of __________. [Hint]

    extensive screening

    doctors error in ordering

    reflex testing

    prospective ordering

    6 . In a fee-for-service system, laboratory testing is considered ________ to the hospital. [Hint]revenue

    unnecessary

    wasteful

    a cost

    7 . You are asked to be a member of a team designing a cost-efficient quality care protocol for patients receiving anticoagulant therapy.This is an example of: [Hint]

    clinical pathway development

    http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700803.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700803.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700803.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700804.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700804.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700804.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700805.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700805.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700805.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700806.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700806.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700806.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700807.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700807.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700807.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700808.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700808.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700808.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700809.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700809.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700809.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700809.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700808.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700807.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700806.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700805.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700804.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700803.cw/hint/index.html');
  • 7/28/2019 Final Exam Quiz

    2/75

    reflexive testing development

    prospective care protocol

    disease management

    8 . Which of the following is NOT a method to help control costs of medical care? [Hint]

    clinical pathway development

    disease management

    fee-for-service plans

    reflexive testing

    9 . An increase in the concentration of neutrophils in the peripheral blood is most commonly due to: [Hint]

    blood loss

    infection

    poor diet

    increasing age

    10.

    Your laboratory hematology team decides to create a testing protocol that will help physicians identify the cause of anemia. This is anexample of: [Hint]

    reflexive testing

    capitated testing

    prospective testing

    critical pathway development

    Cellular Homeostasis and HematopoiesisLevel I Multiple Choice

    1 . The protein kinase responsible for triggering the sequential steps in the cell-division cycle is: [Hint]

    cyclin

    Cdk

    Cdk inhibitor

    p21

    2 . Apoptosis is best described as: [Hint]

    pathologic cell death resulting

    accelerated differentiation

    programmed cell death

    terminal differentiation and loss of ability to undergo proliferation

    3 . Which of the following are considered to be initiators of apoptosis? [Hint]

    growth factor withdrawal

    http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700810.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700810.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700810.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700811.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700811.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700811.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700812.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700812.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700812.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700823.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700823.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700823.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700824.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700824.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700824.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700825.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700825.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700825.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700825.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700824.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700823.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700812.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700811.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700810.cw/hint/index.html');
  • 7/28/2019 Final Exam Quiz

    3/75

    loss of attachment to extracellular matrix

    cell-damaging stress

    all of the above

    4 . All of the following are events regulated by apoptosis EXCEPT: [Hint]

    elimination of autoreactive lymphocytes

    elimination of expanded lymphocytes following cessation of immune response

    elimination of expanded erythrocytes following cessation of hypoxic episode

    elimination of expanded phagocytic cells following cessation of infection/inflammatory response

    5 . Differentiation is best described as: [Hint]

    a. the appearance of different properties in cells that were initially equivalent

    the instance when two cells, derived from the same precursor, take separate routes of development

    the totality of phenomena that begins with commitment and ends when the cell has all of its characteristics

    The "aging" or senescence of a cell

    6 . The morphologically recognizable population of hematopoietic precursor cells, capable of amplification by proliferation, is the: [Hint]

    mature cells

    stem cells

    maturing cells

    progenitor cells

    7 . Hematopoietic growth factors exert all of the following effects on hematopoietic cells EXCEPT: [Hint]

    promote cell survival by suppressing apoptosis

    promote cell proliferation

    regulate the processes of differentiation

    promote senescence

    8 . All of the following are characteristics of hematopoietic growth factors EXCEPT: [Hint]

    Most growth factors are produced by stromal cells in the microenvironment.

    Individual growth factors, by themselves, are poor stimulators of colony growth.

    Most growth factors are relatively lineage-specific.

    Growth factors commonly act synergistically with other cytokines.

    9 . All of the following are considered early-acting (multilineage) growth factors EXCEPT: [Hint]

    stem cell factor

    thrombopoietin

    Flt3 ligand

    GM-CSF

    http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700826.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700826.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700826.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700827.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700827.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700827.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700828.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700828.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700828.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700829.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700829.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700829.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700830.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700830.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700830.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700831.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700831.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700831.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700831.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700830.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700829.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700828.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700827.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700826.cw/hint/index.html');
  • 7/28/2019 Final Exam Quiz

    4/75

    10 . A gene with the capacity to transform a cell into a malignant phenotype is a/an: [Hint]

    proto-oncogene

    tumor suppressor gene

    oncogene

    anti-oncogene

    Cellular Homeostasis and HematopoiesisLevel II Multiple Choice

    1 . The cyclin that is synthesized in response to growth factor stimulation, and is responsible for G1 progression, is: [Hint]

    Cyclin A

    Cyclin B

    Cyclin D

    Cyclin E

    2 . The cell cycle regulatory protein that functions to inhibit cell cycling by sequestering transcription factors required for cell cycle progression from

    G1/S is: [Hint]Rb

    p53

    E2F

    p21

    3 . The protein responsible for monitoring for DNA damage, and the integrity of the genome, is: [Hint]

    Rb

    p53

    E2F

    p16

    4 . The Bcl-2 family of proteins, important in regulating activation of execution caspases, is located: [Hint]

    free in the cytosol

    associated with the cellular membrane

    associated with the mitochondrial membrane

    associated with the endoplasmic reticulum membrane

    5 . Which of the following is considered an example of a death cytokine/death receptor pair? [Hint]

    kit ligand/kit receptor

    flt3 ligand/flt receptor

    fas ligand/fas receptor

    mpl/mpl receptor

    6 . All of the following are considered diseases associated with increased apoptosis EXCEPT: [Hint]

    http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700832.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700832.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700832.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700834.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700834.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700834.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700835.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700835.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700835.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700836.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700836.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700836.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700837.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700837.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700837.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700838.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700838.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700838.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700839.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700839.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700839.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700839.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700838.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700837.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700836.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700835.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700834.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700832.cw/hint/index.html');
  • 7/28/2019 Final Exam Quiz

    5/75

    AIDS

    Parkinsons Disease

    Systemic lupus erythematosus

    Aplastic anemia

    7 . All of the following are important regulators of thrombopoiesis except: [Hint]

    TPO

    IL-11

    IL-4

    IL-6

    8 . The adhesive glycoprotein largely responsible for the retention of developing erythrocyte precursors in the bone marrow is: [Hint]

    fibronectin

    hemonectin

    thrombospondin

    glycosaminoglycans

    9 . A major factor in maintaining stem cell quiescence in the hematopoietic microenvironment is: [Hint]

    MIP-1

    TNF

    SCF

    Flt3 ligand

    10.

    Proto-oncogenes encode which of the following regulatory proteins? [Hint]growth factors

    growth factor receptors

    transcription factors

    all of the above

    Structure and Function of Hematopoietic OrgansLevel I Multiple Choice

    1 . The correct sequence of location of hematopoiesis during development is: [Hint]AGM bone marrow liver

    bone marrow liver spleen

    yolk sac liver bone marrow

    yolk sac thymus AGM

    2 . All of the following cell types are found in bone marrow except: [Hint]

    adipocytes

    http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700840.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700840.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700840.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700841.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700841.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700841.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700842.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700842.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700842.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700843.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700843.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700843.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700855.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700855.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700855.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700856.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700856.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700856.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700856.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700855.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700843.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700842.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700841.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700840.cw/hint/index.html');
  • 7/28/2019 Final Exam Quiz

    6/75

    macrophages

    osteoblasts

    thymocytes

    3 . Which of the following is true of the thymus? [Hint]

    It enlarges after adolescence.

    It provides mature macrophages to the rest of the body.

    It has a high rate of cell death.

    It is nonfunctional in old age.

    4 . Which region of the spleen would most likely be normal in an immune-deficient person? [Hint]

    white pulp

    marginal zone

    germinal center

    red pulp

    5 . Both lymph node and spleen have which structure? [Hint]

    B-cell follicle

    marginal zone

    medulla

    red pulp

    Structure and Function of Hematopoietic OrgansLevel II Multiple Choice

    1 . Bone marrow hyperplasia occurs most commonly in association with: [Hint]

    immune response

    marrow fibrosis

    ineffective erythropoiesis

    toxin exposure

    2 . All of the following may cause hypersplenism except: [Hint]

    metastatic tumor

    antibody-coated red blood cells

    clot in the splenic artery

    cirrhosis

    3 . A common cause of lymphadenopathy is: [Hint]

    infection

    liver disease

    http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700857.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700857.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700857.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700858.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700858.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700858.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700859.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700859.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700859.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700861.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700861.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700861.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700862.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700862.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700862.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700863.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700863.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700863.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700863.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700862.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700861.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700859.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700858.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700857.cw/hint/index.html');
  • 7/28/2019 Final Exam Quiz

    7/75

    extramedullary hematopoiesis

    antibody-coated platelets

    4 . Which of the following may occur after splenectomy for blood disorders associated with antibodies directed against blood cells? [Hint]

    decreased platelet count

    removal of antibodies from circulation

    increased numbers of spherocytes

    increased risk of infection

    5 . Hereditary spherocytosis may lead to splenomegaly because of: [Hint]

    increased removal of erythrocytes

    increased lymphoid tissue

    the presence of tumor cells

    the accumulation of undigestible substances

    1 . Which of the following stages in erythrocyte development can be found in both the bone marrow and peripheral blood? [Hint]

    reticulocyte

    pronormoblast

    polychromatophilic normoblast

    orthochromatic normoblast

    2 . A NRBC has the following characteristics: no visible nucleoli, moderate N:C ratio, deeply basophilic cytoplasm, irregular clumping of chromatinon the nuclear rim. These characteristics describe which of the following maturation stages? [Hint]

    orthochromic normoblast

    basophilic normoblast

    pronormoblast

    metarubricyte

    3 . The majority (90%) of the erythrocyte's metabolism for energy production is produced from: [Hint]

    NADH

    2,3-DPG

    glucose

    glycogen

    4 . Predict which of the following erythroid maturation stages would be the most sensitive to erythropoietin stimulation: [Hint]

    polychromatic normoblast

    BFU-E

    reticulocyte

    CFU-E

    5 . The presence of hemosideruria infers which of the following? [Hint]

    http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700864.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700864.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700864.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700865.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700865.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700865.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700876.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700876.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700876.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700877.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700877.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700877.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700878.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700878.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700878.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700879.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700879.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700879.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700880.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700880.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700880.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700880.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700879.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700878.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700877.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700876.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700865.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700864.cw/hint/index.html');
  • 7/28/2019 Final Exam Quiz

    8/75

    increased serum iron

    increased intravascular hemolysis

    increased serum haptoglobin levels

    increased serum ferritin

    6 . The erythrocyte membrane is important in all the following EXCEPT: [Hint]

    maintaining erythrocyte flexibility

    generation of ATP

    maintaining erythrocyte shape

    carrier for cell antigens

    7 . Which of the following describes normal erythrocytes? [Hint]

    contain iron granules

    cell volume between 70 to 100 fL

    mean diameter of 7 - 8

    Life span of 90 days

    8 . In extravascular hemoglobin destruction, heme rings are broken down with the resulting direct production of which of the following? [Hint]

    transferrin

    conjugated bilirubin

    carbon monoxide

    hemopexin

    9 . The body's most common and efficient method of removal of aged or abnormal erythrocyte, and recovery of essential components such as ironand amino acids, is: [Hint]

    intravascular erythrocyte destruction

    red cell fragmentation and removal in the biliary tract

    extravascular erythrocyte destruction

    breakdown of old erythrocytes in the small intestine

    10.

    Which of the following describes the reticulocyte ? [Hint]

    contains RNA

    reference range is 5-15%

    has a pyknotic nucleus

    is smaller than a mature RBC

    HemoglobinLevel I Multiple Choice

    1 . Which of the following is a minor hemoglobincomponent in an adult? [Hint]

    hemoglobin A

    http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700881.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700881.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700881.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700882.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700882.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700882.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700883.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700883.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700883.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700884.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700884.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700884.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700885.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700885.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700885.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700907.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700907.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700907.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700907.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700885.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700884.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700883.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700882.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700881.cw/hint/index.html');
  • 7/28/2019 Final Exam Quiz

    9/75

    hemoglobin A2

    hemoglobin Portland

    hemoglobin Gower I

    2 . The Bohr effect refers to the ability of hemoglobinto: [Hint]

    accept H+

    carry CO2

    exchange Cl-for HCO3

    -

    respond to changes in 2,3-DPG levels

    3 . What effect would iron deficiency have on the rate ofhemoglobin synthesis? [Hint]

    increase it

    decrease it

    no effect

    cant be predicted

    4 . When 2,3-DPG increases, the oxygen affinity ofhemoglobin: [Hint]

    increases

    is unaffected

    decreases

    is unpredictable

    5 . How many iron molecules are present in a moleculeof hemoglobin? [Hint]

    one

    two

    three

    four

    6 . An increase in the concentration of HbA1c is anindication of: [Hint]

    iron deficiency

    methemoglobinemia

    diabetes

    increased HbA

    7 . Which of the following shifts the ODC to theright? [Hint]

    decreased PCO2

    http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700908.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700908.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700908.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700909.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700909.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700909.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700910.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700910.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700910.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700911.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700911.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700911.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700912.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700912.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700912.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700913.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700913.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700913.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700913.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700912.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700911.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700910.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700909.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700908.cw/hint/index.html');
  • 7/28/2019 Final Exam Quiz

    10/75

    increased PO2

    decreased H+

    concentration

    increased temperature

    8 . Which of the following hemoglobins is thepredominant hemoglobin in infants? [Hint]

    hemoglobin A

    hemoglobin A2

    hemoglobin F

    hemoglobin Portland

    9 . Normally, hemoglobin concentration is maintained ina steady state by: [Hint]

    balance in the production and destruction oferythrocytes

    coordination of production of equal quantitiesof and globin chains

    regulation of transferrin receptors

    regulation of destruction of ferritin mRNA

    10.

    A hemoglobin of 160 g/L in an adult male isconsidered: [Hint]

    decreased

    normal

    increased

    borderline abnormal

    HemoglobinLevel II Multiple Choice

    1 . Which of the following is the major hemoglobin found in adults? [Hint]

    22

    22

    22

    22

    2 . Insertion of iron into the protoporphyrin ring takes place in the: [Hint]cytoplasm

    ribosomes

    mitochondria

    nucleus

    3 . Hemoglobin electrophoresis should be considered when a patient has: [Hint]

    methemoglobinemia

    http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700914.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700914.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700914.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700915.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700915.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700915.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700916.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700916.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700916.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700918.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700918.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700918.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700919.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700919.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700919.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700920.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700920.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700920.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700920.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700919.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700918.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700916.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700915.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700914.cw/hint/index.html');
  • 7/28/2019 Final Exam Quiz

    11/75

    carboxyhemoglobinemia

    sulfhemoglobinemia

    elevated glucose level

    4 . A patient has lost blood due to chronic intestinal bleeding, and has no symptoms of anemia although his hemoglobin is 9 g/dL. The bestexplanation for this is: [Hint]

    His ODC curve is shifted left.

    His ODC is shifted right.

    The lab result is in error.

    He has increased synthesis of HbF.

    5 . A one-month-old baby was cyanotic. The methemoglobin level is 12%. Hemoglobin electrophoresis is normal. What additional test should bedone on this baby? [Hint]

    NADPH reductase activity

    reticulocyte count

    isoelectric focusing

    Hemoglobin A1C determination

    6 . A patient with emphysema is treated with long term O2 therapy. Why does this result in an increase in the amount of O2 delivered to thetissues? [Hint]

    The synthesis of erythrocytes is increased.

    The synthesis of 2,3-DPG is enhanced.

    It decreases the amount of O2 expired.

    It increases the PO2 of inspired air.

    7 . What effect does the release of O2 in the capillaries have on the H+ concentration in tissues? [Hint]

    increases it

    decreases it

    has no effect

    variable effect

    8 . You are a healthy male from New York who normally does 60 minutes of aerobic exercise daily. While on vacation, you climb to 8,000 feetabove sea level at a mountain resort. Your heart rate is rapid and you are breathing fast. You feel dizzy. What is the best explanation for this setof symptoms? [Hint]

    the atmospheric PO2 is increased

    the atmospheric PO2 is decreased

    your hemoglobin content is decreased

    you have hypothermia

    9 . In iron deficiency, you would expect which of the following to occur: [Hint]

    increased synthesis of ferritin

    decreased synthesis of transferrin receptors

    http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700921.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700921.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700921.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700922.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700922.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700922.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700923.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700923.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700923.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700924.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700924.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700924.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700925.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700925.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700925.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700926.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700926.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700926.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700926.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700925.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700924.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700923.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700922.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700921.cw/hint/index.html');
  • 7/28/2019 Final Exam Quiz

    12/75

    decreased ALAS activity

    increased synthesis of globin chains

    10.

    In a child with hemoglobin M, you would expect to find: [Hint]

    abnormal NADPH reductase activity

    shift to the right in ODC

    shift to the left in ODC

    an improvement after treatment with ascorbic acid

    The LeukocyteLevel l Multiple Choice

    1 . Diapedesis refers to cell movement: [Hint]

    through the blood stream

    through endothelial cells

    in the tissues

    in the bone marrow

    2 . The first morphologically identifiable cell in the granulocytic series is: [Hint]

    CFU-GM cell

    CFU- G progenitor cell

    CD34+ cell

    myeloblast

    3 . Traditionally, the hallmark of differentiating myeloblasts from promyelocytes morphologically has been the visual identification of ____ in thepromyelocytes: [Hint]

    primary granules

    secondary granules

    loss of nucleoli

    pink cytoplasm

    4 . Peroxidase containing granules are present in the following granulocytes: [Hint]

    only myeloblasts

    only promyelocytes

    only promyelocytes and myelocytes

    promyelocytes, myelocytes, metamyelocytes, band and segmented neutrophils

    5 . The cells that are polymorphonuclear include: [Hint]

    neutrophils

    monocytes and neutrophils

    neutrophils, basophils, and eosinophils

    http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700927.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700927.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700927.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700939.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700939.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700939.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700940.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700940.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700940.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700941.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700941.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700941.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700942.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700942.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700942.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700943.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700943.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700943.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700943.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700942.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700941.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700940.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700939.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2737/700927.cw/hint/index.html');
  • 7/28/2019 Final Exam Quiz

    13/75

    neutrophils, monocytes, and lymphocytes

    6 . A neutrophils primary function is to:[Hint]

    protect the host from infectious agents

    protect the host from autoimmune destruction

    secrete cytokines to attract monocytes to the site of infection

    secrete cytokines to attract lymphocytes to the site of infection

    7 . The leukocytes responsible for phagocytosis include: [Hint]

    lymphocytes and monocytes

    lymphocytes and macrophages

    monocytes and neutrophils

    eosinophils and basophils

    8 . An adult reference range for monocytes is: [Hint]

    0.0 - 0.45 x 109/L

    0.2 - 0.8 x 109/L

    0.2 - 4.0 x 109/L

    0.2 - 7.0 x 109/L

    9 . Calculate the absolute number of neutrophils given the following information: Total white count = 10 x 109/L. Total RBC count = 5.0 x 10

    12/L,

    Neutrophils = 40%, metamyelocytes = 30%, myelocytes = 20%, and lymphocytes = 10%. [Hint]

    4 x 103/L

    2 x 109/L

    4 x 109

    /L

    20 x 109/L

    10.

    Causes of increased lymphocytes include: [Hint]

    hypersensitivity reactions

    eosinophilia and viral infections

    viral infections

    tuberculosis, Hodgkins, and nonhematologic malignancies

    11.

    Physiologic variations that affect the leukocyte concentration include all of the following except: [Hint]

    pregnancy

    time of day

    race

    weight and height

    12.

    The newborn peripheral blood white cell differential, contrasted to that of adults, is the following finding in a newborns smear:[Hint]

    leukopenia

    http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700944.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700944.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700944.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700945.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700945.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700945.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700946.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700946.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700946.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700947.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700947.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700947.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700948.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700948.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700948.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700949.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700949.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700949.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700950.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700950.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700950.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700950.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700949.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700948.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700947.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700946.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700945.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700944.cw/hint/index.html');
  • 7/28/2019 Final Exam Quiz

    14/75

    leukocytosis

    neutropenia

    monocytosis

    13.

    Immunoglobulin diversity is provided by: [Hint]

    rearrangement of the immunoglobulin light and heavy chains gene segments in B-lymphocytes

    selective translation of portions of immunoglobulin mRNA in the B-lymphocyte

    rearrangement and recombination of gene coding sequences for immunoglobulin in the T-lymphocyte

    rearrangement and recombination of the VH, DH, and JH genes in the T-lymphocyte

    14.

    Causes of monocytosis include: [Hint]

    hypersensitivity reactions

    eosinophilia and viral infections

    viral infections and Bordetella pertussis infections

    tuberculosis, Hodgkins, and nonhematologic malignancies

    15.

    Physiologic variations that affect the leukocyte concentration include all of the following except: [Hint]

    gender

    age

    activity level

    platelet count

    16.

    The most striking difference, when contrasting infants peripheral blood white cell differential to that of adults, is the follow ing finding in aninfants smear:[Hint]

    neutrophilia

    eosinophilia

    monocytosis

    lymphocytosis

    17.

    Immunoglobulin diversity allows the: [Hint]

    B-lymphocyte to produce a variety of specific immunoglobulins that can react with foreign antigens.

    selective translation of portions of immunoglobulin mRNA in the B-lymphocyte

    rearrangement and recombination of gene coding sequences for immunoglobulin in the T-lymphocyte

    rearrangement and recombination of the TCR genes in the T-lymphocyte

    Routine Hematology ProceduresLevel I Multiple Choice

    Top of Form

    1 . Which anticoagulant prevents coagulation by inhibiting thrombin? [Hint]

    lithium heparin

    http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700951.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700951.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700951.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700952.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700952.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700952.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700953.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700953.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700953.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700954.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700954.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700954.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700955.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700955.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700955.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700991.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700991.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700991.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700991.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700955.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700954.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700953.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700952.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700951.cw/hint/index.html');
  • 7/28/2019 Final Exam Quiz

    15/75

    sodium citrate

    EDTA

    sodium fluoride

    2 . When collecting a series of tubes during a phlebotomy, which specimen collection tube should be filled last? [Hint]

    green top

    red top

    blue top

    lavender top

    3 . The 1992 OSHA Bloodborne Pathogens Standard did NOT require laboratory facilities to: [Hint]

    supply phlebotomists with gloves

    implement the use of sharps containers

    mandate vaccination for HCV

    provide training in potential risk of bloodborne pathogens

    4 . Which of the following will NOT affect the phlebotomist's choice of venipuncture site? [Hint]

    presence of an intravenous line

    large hematoma

    invisible but palpatable vein

    previous mastectomy on left side

    5 . What is the function of a microscope's objective? [Hint]

    magnify the image to the eyepieces

    collect the diffracted light from the condenser

    direct the light beam onto the specimen

    project image to the field lens

    6 . An achromat lens will correct: [Hint]

    chromatic aberrations at two colors and field curvature

    spherical aberrations at two colors and chromatic aberrations at two colors

    chromatic aberrations at two colors and spherical aberrations at one colors

    spherical aberrations at three colors and field curvature

    7 . A manual leukocyte count was performed on an EDTA-anticoagulated specimen. The specimen was diluted 1:20 and a total of 132 leukocyteswere counted in the four corner squares of the hemacytometer. What is the leukocyte count? [Hint]

    2.6 x 109/L

    5.3 x 109/L

    6.6 x 109/L

    http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700992.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700992.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700992.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700993.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700993.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700993.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700994.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700994.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700994.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700995.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700995.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700995.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700996.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700996.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700996.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700997.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700997.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700997.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700997.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700996.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700995.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700994.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700993.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700992.cw/hint/index.html');
  • 7/28/2019 Final Exam Quiz

    16/75

    11.0 x 109/L

    8 . The following erythrocyte data were obtained from an EDTA-anticoagulated specimen: erythrocyte count = 3.92 x 1012

    /L, hemoglobin = 11.4g/dL, hematocrit = 34% (.34 L/L). Calculate the MCH. [Hint]

    29.1 pg

    33.5 pg

    67.2 pg

    86.7 pg

    9 . Which diluent is used for manual platelet counts? [Hint]

    1% phyloxine B

    3% acetic acid

    0.85% sodium chloride

    1% ammonium oxalate

    10

    .

    A reticulocyte count was performed using a Miller disk, and 30 reticulocytes (square A) were observed in 290 erythrocytes (square B). What is

    the reticulocyte count? [Hint]0.9%

    1.1%

    2.3%

    3.0%

    11.

    Which of the following will be observed if a purple top collection tube is underfilled? [Hint]

    falsely elevated leukocyte count

    falsely decreased erythrocyte sedimentation rate

    falsely elevated hemoglobin

    falsely decreased reticulocyte count

    12.

    A patient has an elevated fibrinogen level. How will this affect the patient's ESR? [Hint]

    ESR will be unaffected.

    ESR will be elevated.

    ESR will be decreased.

    ESR will be uninterpretable.

    13.

    The clinical laboratory scientist overfilled the second side of the hemacytometer, but carefully removed excess fluid with a kimwipe. What effectwould this have on the hemacytometer cell count? [Hint]

    Result would be unaffected.

    Result would be falsely decreased.

    Result would be falsely increased.

    Result would be equivocal.

    14.

    In performing an examination on a Wright-stained peripheral blood smear, the clinical laboratory professional observes enlarged platelets andvacuolated leukocytes. What is the appropriate course of action? [Hint]

    http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700998.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700998.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700998.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700999.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700999.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700999.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701000.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701000.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701000.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701001.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701001.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701001.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701002.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701002.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701002.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701003.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701003.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701003.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701004.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701004.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701004.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701004.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701003.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701002.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701001.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701000.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700999.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/700998.cw/hint/index.html');
  • 7/28/2019 Final Exam Quiz

    17/75

    Perform a second 100-cell differential.

    Ignore them, since they are artifacts, and report platelet and leukocyte morphology as normal.

    Collect new specimen and prepare blood smear within three hours.

    Send smear for pathology review, since these changes are abnormal.

    15

    .

    The following erythrocyte data were obtained from an EDTA-anticoagulated specimen: erythrocyte count = 2.93 x 10 /L, hemoglobin = 5.9

    g/dL, hematocrit = 21% (.21 L/L). What would you expect to observe on a Wright-stained peripheral blood smear? [Hint]normochromic, normocytic erythrocytes

    hypochromic, microcytic erythrocytes

    normochromic, macrocytic erythrocytes

    hypochromic, normocytic erythrocytes

    16.

    A patient is known to have high levels of sulfhemoglobin. How will this affect the patient's hemoglobin determination? [Hint]

    Result will be unaffected, since sulfhemoglobin is measured by the cyanmethemoglobin method.

    Result will be falsely elevated, since sulfhemoglobin will be precipitated, causing turbidity.

    Result will be falsely decreased, since sulfhemoglobin is not measured by the cyanmethemoglobin method..

    Result must be corrected for the presence of sulfhemoglobin using a correction factor.

    Bottom of Form

    Peripheral Blood SmearLevel I Multiple Choice

    Top of Form

    1 . The microscopic examination of a Wright-stained blood smear revealed bluish-gray erythrocytes and intensely black leukocyte nuclei. What isthe best explanation for this appearance? [Hint]

    The buffer was too acidic.

    The rinsing process was prolonged.

    The blood smear was too thin.

    The Wright stain was too alkaline.

    2 . In the examination of a blood smear, 95 leukocytes were observed in five fields of view. What is the leukocyte estimate? Assume an EDTAblood specimen was used to prepare the smear. [Hint]

    1.9 x 109/L

    3.8 x 109/L

    19.0 x 109/L

    38 x 109/L

    3 . If the leukocyte count in question #2 was 4.5 x 109/L, does the leukocyte estimate correlate? [Hint]

    yes

    no

    4 . A leukocyte count of 28.5 x 109/L was obtained on an EDTA-anticoagulated specimen. Examination of the blood smear revealed 112

    nucleated erythrocytes per 100 leukocytes. What is the corrected leukocyte count? [Hint]

    13.4 x 109/L

    http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701005.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701005.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701005.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701006.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701006.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701006.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701026.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701026.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701026.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701027.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701027.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701027.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701028.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701028.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701028.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701029.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701029.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701029.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701029.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701028.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701027.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701026.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701006.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701005.cw/hint/index.html');
  • 7/28/2019 Final Exam Quiz

    18/75

    16.8 x 109/L

    25.4 x 109/L

    28.5 x 109/L

    5 . Which component of Wrights stain is responsible for the red-orange color of an erythrocyte? [Hint]

    azure B

    methylene blue

    eosin

    methanol

    6 . A patient's CBC results included an MCV = 72 fL, MCH = 30 pg, and MCHC = 33%. What would you expect to observe for the erythrocytemorphology? [Hint]

    normochromic and normocytic

    normochromic and microcytic

    normochromic and macrocytic

    hypochromic and microcytic

    7 . If you observe platelet satellitism on the Wright-stained blood smear of a patient, what CBC parameter should you check for accuracy? [Hint]

    platelet count

    WBC count

    RBC count

    reticulocyte count

    8 . You count 15 platelets in each of five microscopic fields at 100x magnification on a Wright stained blood smear. What is the approximate

    platelet count? [Hint]500 x 10

    9/L

    225 x 109/L

    100 x 109/L

    23 x 109/L

    9 . You count about six platelets per field at 100x magnification on a Wright-stained smear. What is the most accurate description of the plateletcount? [Hint]

    normal

    decreased

    increased

    cant tell from this information

    10.

    One day the clinical laboratory technician notices that all blood smears examined under the microscope show crenated red blood cells. What isthe potential problem ? [Hint]

    The smears are too thin.

    The room is too cold.

    http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701030.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701030.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701030.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701031.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701031.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701031.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701032.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701032.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701032.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701033.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701033.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701033.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701034.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701034.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701034.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701035.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701035.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701035.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701035.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701034.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701033.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701032.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701031.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701030.cw/hint/index.html');
  • 7/28/2019 Final Exam Quiz

    19/75

    The smear is too thick.

    The smears are dried too slowly.

    Bottom of FormPeripheral Blood SmearLevel II Multiple Choice

    1 . A patient with a history of polycythemia is seen for a routine checkup. What might the clinical laboratory personnel have to do to prepare anoptimal blood smear? [Hint]

    Decrease the angle of the spreader slide and decrease the push speed.

    Decrease the angle of the spreader slide and increase the push speed.

    Increase the angle of the spreader slide and increase the push speed.

    Increase the angle of the spreader slide and decrease the push speed.

    2 . Initial examination of a Wright-stained blood smear reveals bright red erythrocytes and very pale leukocyte nuclei. To correct this improperstaining, the clinical laboratory professional should: [Hint]

    Decrease the staining time.

    Prepare a thinner blood smear.

    Decrease the pH of the stain.

    Increase the pH of the buffer

    3 . In examining the patient's Wright-stained blood smear, the clinical laboratory professional noted the presence of platelet clumps. How would anaccurate platelet estimate be obtained on this patient? [Hint]

    Warm specimen to 37oC for 15 minutes, then prepare peripheral blood smear.

    Allow specimen to set at 25oC for five hours, then prepare peripheral blood smear.

    Recollect specimen in citrate and prepare peripheral blood smear.

    No corrective action is available.

    4 . A peripheral blood smear examination of a Wright-stained blood smear revealed leukocytes with cytoplasmic vacuolization and karyorrhexis ofthe nucleus. What action should be taken to determine if these changes are true or artifact? [Hint]

    Prepare and stain a second smear after blood has stabilized for four hours.

    Recollect the specimen and prepare blood smear immediately.

    Mix a portion of the blood with 22% albumin and prepare a blood smear.

    Collect specimen using heparin and prepare a blood smear.

    5 . A patient has cold agglutinin disease. How can a good blood smear be made from this patients blood?[Hint]

    Dry the smear quickly.

    Decrease the angle of the spreader slide.

    Press hard on the spreader slide

    Warm the blood to 37 degrees C before making the smear.

    6 . A new employee complains that the staining procedure is washing all the blood off the slide. What is the likely problem? [Hint]

    The stain is old.

    The blood smear is too thick.

    http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701037.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701037.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701037.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701038.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701038.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701038.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701039.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701039.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701039.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701040.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701040.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701040.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701041.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701041.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701041.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701042.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701042.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701042.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701042.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701041.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701040.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701039.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701038.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701037.cw/hint/index.html');
  • 7/28/2019 Final Exam Quiz

    20/75

    The step with methanol is being skipped.

    The buffer is too acid.

    7 . You want to determine if a patients platelet count is falsely decreased due to platelet clumping. What is the most appropriate action totake? [Hint]

    Examine the stained blood smear at 1000X.

    Examine the stained blood smear at 100X.

    Shake the EDTA tube vigorously and reanalyze.

    Collect the blood in lithium heparin and reanalyze.

    8 . You note rouleaux on the stained periperal blood smear. How will this affect the CBC? [Hint]

    This will not affect the CBC.

    The WBC count will be falsely decreased.

    The RBC count will be falsely decreased.

    The platelet count will be falsely increased.

    9 . You are doing a differential count on a peripheral blood smear and note that there are many smudge cells present. What should you do? [Hint]

    Add 1 drop of saline to a drop of blood and make another smear.

    Add a lysing agent to the patients blood and make another smear.

    Add 1 drop of albumin to 5 drops of blood and make another smear.

    Recollect the blood in citrate and make another smear.

    10.

    A renal dialysis patient has a hematocrit of 15%. What adaptation can you make to assure a good blood smear? [Hint]

    Increase the angle of the spreader slide and push speed.

    Decrease the angle of the spreader slide and push speed.

    Increase the angle of the spreader slide and decrease push speed.

    Decrease the angle of the spreader slide and decrease push speed.

    Bone MarrowLevel I Multiple Choice

    1 . What is the preferred site for bone marrow aspiration in adults? [Hint]

    posterior iliac crest

    vertebral bodies

    tibia

    sternum

    2 . Which of the following are indications for a bone marrow biopsy? [Hint]

    35-year-old HIV-positive male with fever of unknown origin

    60-year-old male with anemia secondary to malignancy

    20-year-old woman with iron deficiency

    http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701043.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701043.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701043.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701044.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701044.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701044.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701045.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701045.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701045.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701046.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701046.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701046.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701057.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701057.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701057.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701058.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701058.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701058.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701058.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701057.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701046.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701045.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701044.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701043.cw/hint/index.html');
  • 7/28/2019 Final Exam Quiz

    21/75

    a child with infectious mononucleosis

    3 . The anteromedial surface of the tibia is sometimes used for bone marrow aspiration in: [Hint]

    patients more than 60 years old

    children less than 2 years old

    women in their 30s

    adults

    4 . Which of the following is not an indication for a bone marrow biopsy? [Hint]

    Pancytopenia with rare circulating blasts

    Thrombocytopenia with rare circulating blasts

    Mild leukocytosis after receiving growth factor

    Unexplained anemia and leukopenia

    5 . Which bone marrow sample is best for evaluating cell morphology and performing the differential count? [Hint]

    aspirate

    biopsy

    clot section

    touch prep

    6 . The normal M:E ratio ranges between: [Hint]

    1: 2 to 1: 4

    2: 1 to 4: 1

    1: 4 to 1: 6

    4: 1 to 6: 1

    7 . A pathologist examined the core biopsy of a 50-year old male. The overall cellularity is 20%. Interpret this finding. [Hint]

    Normocellular marrow for age

    Hypercellular marrow for age

    Hypocellular marrow for age

    You cannot estimate from a core biopsy.

    8 . A physician is evaluating a patient with systemic lupus erythematosus. The patient is anemic. There is difficulty interpreting the serum ironstudies. The anemia could be due to chronic disease secondary to lupus or iron deficiency. A bone marrow biopsy was performed. What specialstain should be used to evaluate the marrow? [Hint]

    myeloperoxidase

    Sudan black B

    Prussian blue

    new methylene blue

    9 . A physician did a bone marrow biopsy in a patient with previous diagnosis of primary myelofibrosis. He wants to evaluate the degree of fibrosis.What stain should be used?[Hint]

    http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701059.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701059.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701059.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701060.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701060.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701060.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701061.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701061.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701061.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701062.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701062.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701062.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701063.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701063.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701063.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701064.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701064.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701064.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701065.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701065.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701065.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701065.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701064.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701063.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701062.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701061.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701060.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701059.cw/hint/index.html');
  • 7/28/2019 Final Exam Quiz

    22/75

    Reticulin

    Prussian blue

    myeloperoxidase

    TdT

    10

    .

    Why would special stains such as myeloperoxidase be performed on a bone marrow specimen? [Hint]

    to differentiate types of anemia

    to differentiate types of leukemia

    to evaluate cellularity

    to determine M:E ratio

    Bone Marrow

    Level II Multiple Choice

    1 . A 20-year-old male with suspicion of acute leukemia had a bone marrow biopsy. His platelet count is 30 x 10 L. The man is oozing from thebiopsy site. What should be done? [Hint]

    Request platelets from the blood bank for platelet transfusion.

    Transfuse the patient with fresh frozen plasma.

    Apply local pressure and ask the patient to lie on his back. Watch the bleeding site periodically.

    Give factor VIII concentrate.

    2 . You are in the laboratory to process a bone marrow biopsy. The patient is suspected to have acute leukemia. The physician who performed thebone marrow couldnt get any aspirate. You see several unstained slides that appear to be bone marrow imprints. What is the best way to usethese slides? [Hint]

    Stain all slides with Wright-Giemsa.

    Stain a few slides with Wright-Giemsa; save the unstained slides for possible cytochemical stains.

    Stain a couple of slides with Wright-Giemsa. You cannot perform cytochemical stains on bone marrow imprints.

    Perform routine cytogenetics on unstained slides.

    3 . A patient is suspected of having an acute leukemia. His bone marrow revealed 40% blasts. What ancillary study can be done on the bonemarrow aspirate in almost any laboratory to determine the lineage of the blasts? [Hint]

    molecular diagnostics

    cytogenetics

    flow cytometry

    cytochemical stains

    4 . A pathologist is evaluating a bone marrow aspirate performed on a 10-month-old boy who required a bone marrow for a non-hematolymphoidmalignancy. He sees an increased number of small, lymphoid-appearing cells with high nuclear cytoplasmic ratio and fine chromatin that looksimilar to blasts. What are these cells? [Hint]

    mature lymphocytes

    hematogones: normal lymphoid progenitor cells

    immature megakaryocytes

    normal erythroid precursors

    http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701066.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701066.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701066.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701068.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701068.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701068.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701069.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701069.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701069.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701070.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701070.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701070.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701071.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701071.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701071.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701071.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701070.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701069.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701068.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701066.cw/hint/index.html');
  • 7/28/2019 Final Exam Quiz

    23/75

    5 . The following is the bone marrow differential obtained in a patient with a recent diagnosis of chronic myeloid leukemia: Blasts 2%, promyelocytes10%, myelocytes 40%, metamyelocytes 20%, bands 5%, segmented neutrophils 10%, basophils 3%, pronormoblasts 2%, basophilicnormoblasts 3%, polychromatophilic normoblasts 3%, orthochromatophilic normoblasts 2%. What is the M:E ratio? [Hint]

    9:1

    11:1

    10:1

    5:1

    6 . What is the overall bone marrow cellularity expected in a 30-year-old woman? [Hint]

    100%

    60 to 80%

    20%

    10%

    7 . A pathologist is evaluating a bone marrow and saw morphologic features suggestive of a myelodysplastic syndrome. She wants to know if theseare ringed sideroblasts. What sample is not suitable to evaluate ringed sideroblasts?" [Hint]

    aspirate smear

    core biopsy

    clot preparation

    particle smears

    8 . A 50-year-old male with neutropenia and splenomegaly had a bone marrow biopsy. The bone marrow revealed 60% blasts. On the peripheralblood smear are several suspicious, blast-like cells. The diagnosis is leukemia. Why do ancillary studies need to be done? [Hint]

    to determine the lineage of the blasts

    to determine if the leukemia is secondary to exposure to toxins

    to determine the presence or absence of oncogenes

    to get a more accurate blast count in the bone marrow

    9 . You are assisting a physician with a bone marrow biopsy. The patient is a 30-year-old male suspected of having acute leukemia. He was able toobtain a good bone marrow aspirate and a good core biopsy. He wants to make sure you send material for flow cytometry and cytogenetics.What is the best way to divide the material you have for the different labs? [Hint]

    Make several smears out of the aspirate for morphology and possible special stains. Allocate the remaining aspirate material into twotubes, an EDTA tube for flow cytometry and a heparin tube for cytogenetics. Fix the entire core biopsy in formalin.

    Use all aspirate, making smears for morphology and special stains. Divide the core biopsy in two and send one piece for the flow lab andone piece for the cytogenetics lab.

    Allocate the aspirate material in two EDTA tubes, one for the flow lab and one for cytogenetics. Dont make aspirate smears. P lace thecore biopsy in formalin.

    None of the above is correct.

    10.

    A patient has had several bone marrow biopsies. The number of lymphocytes varied significantly from one specimen to another. What could bethe possible explanation for this? [Hint]

    The patient had a viral infection during one of the procedures.

    A lymphoid follicle may have been aspirated in one procedure.

    There is a mix-up of patient specimens.

    Not enough cells were counted in the differential to get a good distribution.

    1 . A cell with an MCV of 69 fL is called a(n): [Hint]

    http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701072.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701072.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701072.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/10/2738/701073.cw/hint/index.html');http://openhint%28%27/chet_mckenzie_clinicallabhema_1/1